motilin-(1-19) (human) [5295]
motilin-(1-19) (human)
| SMILES |
CCC(C)C(NC(=O)C1CCCN1C(=O)C(NC(=O)C(N)Cc1ccccc1)C(C)C)C(=O)NC(Cc1ccccc1)C(=O)NC(C(=O)NC(Cc1ccc(O)cc1)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCSC)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(N)=O)C(=O)O)C(C)O |
| InChIKey |
MGEPJYBDTTYXQQ-UHFFFAOYSA-N |
| Sequence |
FVPIFTYGELQRMQEKERN |
| HELM |
PEPTIDE1{F.V.P.I.F.T.Y.G.E.L.Q.R.M.Q.E.K.E.R.N}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
None |
| Hydrogen bond donors |
None |
| Rotatable bonds |
None |
| Log P |
None |
| Molecular weight (Da) |
None |
No bioactivity data available.
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.